From NAFLD in clinical practice to answers from guidelines

Journal of Hepatology

Volumn 59, Issue 4, 2013, Pages 859-871

  Nascimbeni, Fabio ^a   Pais, Raluca ^b   Bellentani, Stefano ^c   Day, Christopher Paul ^d   Ratziu, Vlad ^b   Loria, Paola ^a   Lonardo, Amedeo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b INSERM   (France)

^c AUSL Modena   (Italy)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Clinical practice; Guidelines; NAFLD

Indexed keywords

ALPHA TOCOPHEROL; PIOGLITAZONE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; CARDIOVASCULAR RISK; COST UTILITY ANALYSIS; DRUG MEGADOSE; FAMILIAL HYPOBETALIPOPROTEINEMIA; FOLLOW UP; HUMAN; HYPERTRANSAMINASEMIA; LIFESTYLE MODIFICATION; LIVER BIOPSY; LOW CALORY DIET; MUSCLE TRAINING; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SCREENING; SYSTEMATIC REVIEW; TELEPHONE INTERVIEW; WEIGHT REDUCTION;

AASLD; ACG; AFLD; AGA; ALCOHOLIC FATTY LIVER DISEASE; AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASE; AMERICAN COLLEGE OF GASTROENTEROLOGY; AMERICAN GASTROENTEROLOGICAL ASSOCIATION; APWP; ASIAN-PACIFIC WORKING PARTY; CARDIOVASCULAR DISEASE; CHINESE LIVER DISEASE ASSOCIATION; CHRONIC LIVER DISEASE; CLD; CLDA; CLINICAL PRACTICE; CVD; EASL; ESPGHAN; EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER; EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION; GENERAL PRACTITIONERS; GPS; GUIDELINES; HCC; HEPATOCELLULAR CARCINOMA; IASL; INSULIN RESISTANCE; IR; ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER; LB; LIVER BIOPSY; LIVER TESTS; LTS; METABOLIC RISK FACTORS; METABOLIC SYNDROME; MRFS; MS; NAFLD; NASH; NON-ALCOHOLIC FATTY LIVER DISEASE; NON-ALCOHOLIC STEATOHEPATITIS; T2D; TYPE 2 DIABETES; ULTRASONOGRAPHY; US;

BIOPSY; FATTY LIVER; GASTROENTEROLOGY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 84884419004     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.05.044     Document Type: Review

References (136)

1. A. Kotronen, and H. Yki-Järvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38
2. E. Vanni, E. Bugianesi, A. Kotronen, S. De Minicis, H. Yki-Järvinen, and G. Svegliati-Baroni From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42 2010 320 330
3. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 2006 S99 S112
4. S.R. Weston, W. Leyden, R. Murphy, N.M. Bass, B.P. Bell, and M.M. Manos Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease Hepatology 41 2005 372 379 (Pubitemid 40165382)
5. G. Musso, R. Gambino, M. Cassader, and G. Pagano Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 2011 617 649
6. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, L. Thorelius, M. Holmqvist, and G. Bodemar Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873 (Pubitemid 46489550)
7. C. Soderberg, P. Stal, J. Askling, H. Glaumann, G. Lindberg, and J. Marmur Decreased survival of subjects with elevated liver function tests during a 28-year follow-up Hepatology 51 2010 595 602
8. I. Grattagliano, G. D'Ambrosio, V.O. Palmieri, A. Moschetta, G. Palasciano, and P. Portincasa "Steatostop Project" Group. Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program J Gastrointest Liver Dis 17 2008 389 394
9. J.B. Kallman, A. Arsalla, V. Park, S. Dhungel, P. Bhatia, and D. Haddad Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians Aliment Pharmacol Ther 29 2009 1019 1024
10. C. Loguercio, A. Tiso, G. Cotticelli, V. Blanco Cdel, G. Arpino, and M. Laringe Management of chronic liver disease by general practitioners in southern Italy: unmet educational needs Dig Liver Dis 43 2011 736 741
11. C.J. Bergqvist, R. Skoien, L. Horsfall, A.D. Clouston, J.R. Jonsson, and E.E. Powell Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists Intern Med J 43 2013 247 253
12. V. Ratziu, J.F. Cadranel, L. Serfaty, J. Denis, C. Renou, and P. Delassalle A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France J Hepatol 57 2012 376 383
13. C.M. Leung, L.S. Lai, W.H. Wong, K.H. Chan, Y.W. Luk, and J.Y. Lai Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong J Gastroenterol Hepatol 24 2009 1786 1790
14. L.M. Sivertsen, S.R. Woolfenden, H.J. Woodhead, and D. Lewis Diagnosis and management of childhood obesity: a survey of general practitioners in South West Sydney J Paediatr Child Health 44 2008 622 629
15. M. Fishbein, J. Mogren, C. Mogren, S. Cox, and R. Jennings Undetected hepatomegaly in obese children by primary care physicians: a pitfall in the diagnosis of pediatric nonalcoholic fatty liver disease Clin Pediatr (Phila) 44 2005 135 141 (Pubitemid 40344403)
16. M.R. Riley, N.M. Bass, P. Rosenthal, and R.B. Merriman Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists J Pediatr 147 2005 839 842 (Pubitemid 41774844)
17. V. Ratziu, S. Bellentani, H. Cortez-Pinto, C. Day, and G. Marchesini A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 2010 372 384
18. G.C. Farrell, S. Chitturi, G.K. Lau, and J.D. Sollano Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary J Gastroenterol Hepatol 22 2007 775 777 (Pubitemid 46911045)
19. J.G. Fan, J.D. Jia, Y.M. Li, B.Y. Wang, L.G. Lu, and J.P. Shi Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010 (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166) J Dig Dis 12 2011 38 44
20. P. Loria, L.E. Adinolfi, S. Bellentani, E. Bugianesi, A. Grieco, and S. Fargion Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee Dig Liver Dis 42 2010 272 282
21. N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, and K. Cusi The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 55 2012 2005 2023
22. P. Vajro, S. Lenta, P. Socha, A. Dhawan, P. McKiernan, and U. Baumann Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee J Pediatr Gastroenterol Nutr 54 2012 700 713
23. Adult Treatment Panel III Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
24. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published corrections appear in Circulation 2005; 112:e297 and Circulation 2005;112:e298] Circulation 2005 112 2005 2735 2752
25. K.G. Alberti, P. Zimmet, J. Shaw, and IDF Epidemiology Task Force Consensus Group The metabolic syndrome: a new worldwide definition Lancet 366 2005 1059 1062 (Pubitemid 41338752)
26. A. Lonardo, C. Carani, N. Carulli, and P. Loria 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis J Hepatol 44 2006 1196 1207
27. P. Tarugi, A. Lonardo, G. Ballarini, A. Grisendi, M. Pulvirenti, and A. Bagni Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B Gastroenterology 111 1996 1125 1133 (Pubitemid 26327617)
28. D.L. White, V. Ratziu, and H.B. El-Serag Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis J Hepatol 49 2008 831 844
29. A. Lonardo, N. Carulli, and P. Loria HCV and diabetes. A two-question-based reappraisal Dig Liver Dis 39 2007 753 761 (Pubitemid 47046641)
30. A. Lonardo, L.E. Adinolfi, S. Petta, A. Craxì, and P. Loria Hepatitis C and diabetes: the inevitable coincidence? Exp Rev Anti Infect Ther 7 2009 293 308
31. S. Naveau, V. Giraud, E. Borotto, A. Aubert, F. Capron, and J.C. Chaput Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108 111 (Pubitemid 27014994)
32. E.E. Powell, J.R. Jonsson, and A.D. Clouston Steatosis: co-factor in other liver diseases Hepatology 42 1 2005 5 13 (Pubitemid 40911303)
33. E.E. Powell, A. Ali, A.D. Clouston, J.L. Dixon, D.J. Lincoln, and D.M. Purdie Steatosis is a cofactor in liver injury in hemochromatosis Gastroenterology 129 2005 1937 1943 (Pubitemid 41772971)
34. G. Leandro, A. Mangia, J. Hui, P. Fabris, L. Rubbia-Brandt, and G. Colloredo HCV Meta-Analysis (on) Individual Patients' Data Study Group. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
35. S. Petta, C. Cammà, V. Di Marco, F.S. Macaluso, M. Maida, and G. Pizzolanti Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection Liver Int 31 2011 507 515
36. J. Levitsky, and M.E. Mailliard Diagnosis and therapy of alcoholic liver disease Semin Liver Dis 24 2004 233 247 (Pubitemid 39167682)
37. M.L. Hannuksela, M.K. Liisanantti, A.E. Nissinen, and M.J. Savolainen Biochemical markers of alcoholism Clin Chem Lab Med 45 2007 953 961 (Pubitemid 47424855)
38. F. Scaglioni, S. Ciccia, M. Marino, G. Bedogni, and S. Bellentani ASH and NASH Dig Dis 29 2011 202 210
39. P. Marks, and R. Williams Calorie and alcohol consumption in nonalcoholic fatty liver disease Eur J Gastroenterol Hepatol 24 2012 527 530
40. H. Völzke Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin? World J Gastroenterol 21 2012 3492 3501
41. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
42. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, and J.C. Cohen Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395 (Pubitemid 39657013)
43. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 42 2005 44 52 (Pubitemid 40911310)
44. J.Y. Lee, K.M. Kim, S.G. Lee, E. Yu, Y.S. Lim, and H.C. Lee Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center J Hepatol 47 2007 239 244 (Pubitemid 47021248)
45. H. Li, Y.J. Wang, K. Tan, L. Zeng, L. Liu, and F.J. Liu Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China Hepatobiliary Pancreat Dis Int 8 2009 377 382
46. N. Assy, K. Kaita, D. Mymin, C. Levy, B. Rosser, and G. Minuk Fatty infiltration of liver in hyperlipidemic patients Dig Dis Sci 45 2000 1929 1934
47. M. Machado, P. Marques-Vidal, and H. Cortez-Pinto Hepatic histology in obese patients undergoing bariatric surgery J Hepatol 45 2006 600 606 (Pubitemid 44307393)
48. N.C. Leite, G.F. Salles, A.L. Araujo, C.A. Villela-Nogueira, and C.R. Cardoso Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus Liver Int 29 2009 113 119
49. V.M. Struben, E.E. Hespenheide, and S.H. Caldwell Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds Am J Med 108 2000 9 13 (Pubitemid 30058272)
50. A. Lonardo, A. Bagni, P. Tarugi, and P. Loria The wide spectrum of steatohepatitis: a report of four cases and a review of the literature Eur J Gastroenterol Hepatol 16 2004 1043 1050 (Pubitemid 39411124)
51. I.R. Willner, B. Waters, S.R. Patil, A. Reuben, J. Morelli, and C.A. Riely Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease Am J Gastroenterol 96 2001 2957 2961 (Pubitemid 32959539)
52. J.B. Schwimmer, M.A. Celedon, J.E. Lavine, R. Salem, N. Campbell, and N.J. Schork Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
53. R.K. Dhiman, A. Duseja, and Y. Chawla Asians need different criteria for defining overweight and obesity Arch Intern Med 165 2005 1069 1070 (Pubitemid 40638133)
54. S. Chitturi, G.C. Farrell, E. Hashimoto, T. Saibara, G.K. Lau, J.D. Sollano, and Asia-Pacific Working Party on NAFLD Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines J Gastroenterol Hepatol 22 2007 778 787 (Pubitemid 46915352)
55. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications-part 1: diagnosis and classification of diabetes mellitus 1999 World Health Organization Geneva pp. 20-21
56. H.J. Kim, H.J. Kim, K.E. Lee, D.J. Kim, S.K. Kim, and C.W. Ahn Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults Arch Intern Med 164 2004 2169 2175
57. Z.M. Younossi, M. Stepanova, F. Negro, S. Hallaji, Y. Younossi, and B. Lam Nonalcoholic fatty liver disease in lean individuals in the United States Medicine (Baltimore) 91 2012 319 327
58. B. Vos, C. Moreno, N. Nagy, F. Féry, M. Cnop, and P. Vereerstraeten Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease Acta Gastroenterol Belg 74 2011 389 394
59. K. Das, K. Das, P.S. Mukherjee, A. Ghosh, S. Ghosh, and A.R. Mridha Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease Hepatology 51 2010 1593 1602
60. P. Jepsen, H. Vilstrup, L. Mellemkjaer, A.M. Thulstrup, J.H. Olsen, and J.A. Baron Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study Hepatogastroenterology 50 2003 2101 2104 (Pubitemid 37468003)
61. L.A. Adams, J.F. Lymp, J. St Sauver, S.O. Sanderson, K.D. Lindor, and A. Feldstein The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121 (Pubitemid 41002048)
62. J.P. Ong, A. Pitts, and Z.M. Younossi Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease J Hepatol 49 2008 608 612
63. W. Dunn, R. Xu, D.L. Wingard, C. Rogers, P. Angulo, and Z.M. Younossi Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study Am J Gastroenterol 103 2008 2263 2271
64. R. Haring, H. Wallaschofski, M. Nauck, M. Dorr, S.E. Baumeister, and H. Volzke Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels Hepatology 50 2009 1403 1411
65. N. Rafiq, C. Bai, Y. Fang, M. Srishord, A. McCullough, and T. Gramlich Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 2009 234 238
66. H.T. Sørensen, L. Mellemkjaer, P. Jepsen, A.M. Thulstrup, J. Baron, and J.H. Olsen Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study J Clin Gastroenterol 36 2003 356 359 (Pubitemid 36331620)
67. V.W. Wong, G.L. Wong, S.W. Tsang, T. Fan, W.C. Chu, and J. Woo High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis Gut 60 2011 829 836
68. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140 (Pubitemid 34747534)
69. G. Baffy, E.M. Brunt, and S.H. Caldwell Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace J Hepatol 56 2012 1384 1391
70. A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. Davey Smith, and D.A. Lawlor Alanine transaminase, gamma-glutamyltransferase, and incident diabetes: the British women's heart and health study and meta-analysis Diab Care 32 2009 741 750
71. T. Yamada, M. Fukatsu, S. Suzuki, T. Wada, T. Yoshida, and T. Joh Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup J Gastroenterol Hepatol 25 2010 352 356
72. S. Sookoian, and C.J. Pirola Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review J Hepatol 49 2008 600 607
73. G. Targher, C.P. Day, and E. Bonora Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 2010 1341 1350
74. V.W. Wong, G.L. Wong, G.W. Yip, A.O. Lo, J. Limquiaco, and W.C. Chu Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease Gut 60 2011 1721 1727
75. M. Kozakova, C. Palombo, M.P. Eng, J. Dekker, A. Flyvbjerg, and A. Mitrakou RISC Investigators. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques Hepatology 55 2012 1406 1415
76. V.E. de Meijer, B.T. Kalish, M. Puder, and J.N. Ijzermans Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection Br J Surg 97 2010 1331 1339
77. S.K. Reddy, J.W. Marsh, P.R. Varley, B.K. Mock, K.B. Chopra, and D.A. Geller Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study Hepatology 56 2012 2221 2230
78. A. Lonardo, S. Sookoian, M. Chonchol, P. Loria, and G. Targher Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD Curr Pharm Des 2013 [in press]
79. B. Palmentieri, I. de Sio, V. La Mura, M. Masarone, R. Vecchione, and S. Bruno The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis Dig Liver Dis 38 2006 485 489 (Pubitemid 44356237)
80. S. Dasarathy, J. Dasarathy, A. Khiyami, R. Joseph, R. Lopez, and A.J. McCullough Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study J Hepatol 51 2009 1061 1067
81. L.S. Szczepaniak, P. Nurenberg, D. Leonard, J.D. Browning, J.S. Reingold, and S. Grundy Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2005 E462 E468
82. A. Kotronen, J. Westerbacka, R. Bergholm, K.H. Pietiläinen, and H. Yki-Järvinen Liver fat in the metabolic syndrome J Clin Endocrinol Metab 92 2007 3490 3497 (Pubitemid 47435325)
83. M. Hamaguchi, T. Kojima, Y. Itoh, Y. Harano, K. Fujii, and T. Nakajima The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation Am J Gastroenterol 102 2007 2708 2715 (Pubitemid 350179336)
84. S. Ballestri, A. Lonardo, D. Romagnoli, L. Carulli, L. Losi, and C.P. Day Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD Liver Int 32 2012 1242 1252
85. P. Mofrad, M.J. Contos, M. Haque, C. Sargeant, R.A. Fisher, and V.A. Luketic Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 37 2003 1286 1292 (Pubitemid 36667307)
86. A.L. Fracanzani, L. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, and E. Vanni Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 2008 792 798
87. D. Prati, E. Taioli, A. Zanella, E. Della Torre, S. Butelli, and E. Del Vecchio Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 2002 1 10
88. H.C. Kim, C.M. Nam, S.H. Jee, K.H. Han, D.K. Oh, and I. Suh Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study BMJ 328 2004 983
89. D. Van der Poorten, D.T. Kenny, T. Butler, and J. George Liver disease in adolescents: a cohort study of high-risk individuals Hepatology 46 2007 1750 1758
90. J.B. Schwimmer, W. Dunn, G.J. Norman, P.E. Pardee, M.S. Middleton, and N. Kerkar SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease Gastroenterology 138 2010 1357 1364
91. W.C. Wu, C.Y. Wu, Y.J. Wang, H.H. Hung, H.I. Yang, and W.Y. Kao Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34346 subjects Aliment Pharmacol Ther 36 2012 560 568
92. M.H. Zheng, K.Q. Shi, Y.C. Fan, W.Y. Liu, X.F. Lin, and L.F. Li Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population PLoS One 7 2012 e43736
93. H. Tilg, and A.R. Moschen Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology 52 2010 1836 1846
94. R. Pais, A. Pascale, L. Fedchuck, F. Charlotte, T. Poynard, and V. Ratziu Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease Clin Res Hepatol Gastroenterol 35 2011 23 28
95. Y. Yilmaz Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther 36 2012 815 823
96. S.A. Harrison, S. Torgerson, and P.H. Hayashi The natural history of nonalcoholic fatty liver disease: a clinical histopathological study Am J Gastroenterol 98 2003 2042 2047 (Pubitemid 37185803)
97. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and L.W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80 (Pubitemid 20075105)
98. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, and C.J. Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669 (Pubitemid 29109578)
99. A. Poonawala, S.P. Nair, and P.J. Thuluvath Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 2000 689 692
100. S.H. Caldwell, and D.M. Crespo The spectrum expanded: cryptogenic cirrhosis and the natural history of nonalcoholic fatty liver disease J Hepatol 40 2004 578 584 (Pubitemid 38367778)
101. A. Maheshwari, and P.J. Thuluvath Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol 101 2006 664 668 (Pubitemid 43340946)
102. V. Ratziu, F. Charlotte, A. Heurtier, S. Gombert, P. Giral, and E. Bruckert LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 2005 1898 1906 (Pubitemid 40824701)
103. P. Angulo, J.M. Hui, G. Marchesini, E. Bugianesi, J. George, and G.C. Farrell The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854 (Pubitemid 46631552)
104. A.E. Feldstein, A. Wieckowska, A.R. Lopez, Y.C. Liu, N.N. Zein, and A.J. McCullough Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study Hepatology 50 2009 1072 1078
105. M.V. Machado, and H. Cortez-Pinto Non-invasive diagnosis of non-alcoholic fatty liver disease-a critical appraisal J Hepatol 58 2013 1007 1019
106. D. Kim, W.R. Kim, H.J. Kim, and T.M. Therneau Association between non-invasive fibrosis markers and mortality among adults with non-alcoholic fatty liver disease in the United States Hepatology 57 2013 1357 1365
107. M. Maurantonio, S. Ballestri, M.R. Odoardi, A. Lonardo, and P. Loria Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? Arch Med Res 42 2011 337 353
108. G. Musso, M. Cassader, F. Rosina, and R. Gambino Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials Diabetologia 55 2012 885 904
109. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
110. S.E. Mahady, G. Wong, J.C. Craig, and J. George Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis Hepatology 56 2012 2172 2179
111. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, and I.K. Moules Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
112. L. Azoulay, H. Yin, K.B. Filion, J. Assayag, A. Majdan, and M.N. Pollak The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study BMJ 344 2012 e3645
113. E.R. Miller 3rd, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality Ann Intern Med 142 2005 37 46
114. E.A. Klein, I.M. Thompson Jr., C.M. Tangen, J.J. Crowley, M.S. Lucia, and P.J. Goodman Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT) JAMA 306 2011 1549 1556
115. V. Ratziu, V. de Ledinghen, F. Oberti, P. Mathurin, C. Wartelle-Bladou, and C. Renou A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis J Hepatol 54 2011 1011 1019
116. N. Chalasani Statins and hepatotoxicity: focus on patients with fatty liver Hepatology 41 2005 690 695 (Pubitemid 40462927)
117. M. Ekstedt, L.E. Franzén, M. Holmqvist, P. Bendtsen, U.L. Mathiesen, and G. Bodemar Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease Scand J Gastroenterol 44 2009 366 374
118. W. Dunn, R. Xu, and J.B. Schwimmer Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease Hepatology 47 2008 1947 1954 (Pubitemid 351945562)
119. A. Moriya, Y. Iwasaki, S. Ohguchi, E. Kayashima, T. Mitsumune, and H. Taniguchi Alcohol consumption appears to protect against non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 2011 378 388
120. W. Dunn, A.J. Sanyal, E.M. Brunt, A. Unalp-Arida, M. Donohue, and A.J. McCullough Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD) J Hepatol 57 2012 384 391
121. S. Liangpunsakul, and N. Chalasani What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 107 2012 976 978
122. V. Paradis, S. Zalinski, E. Chelbi, N. Guedj, F. Degos, and V. Vilgrain Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis Hepatology 49 2009 851 859
123. J.B. Schwimmer, R. Deutsch, T. Kahen, J.E. Lavine, C. Stanley, and C. Behling Prevalence of fatty liver in children and adolescents Pediatrics 118 2006 1388 1393 (Pubitemid 46393782)
124. R. Loomba, C.B. Sirlin, J.B. Schwimmer, and J.E. Lavine Advances in pediatric nonalcoholic fatty liver disease Hepatology 50 2009 1282 1293
125. J.P. Molleston, F. White, J. Teckman, and J.F. Fitzgerald Obese children with steatohepatitis can develop cirrhosis in childhood Am J Gastroenterol 97 2002 2460 2462
126. A.E. Feldstein, P. Charatcharoenwitthaya, S. Treeprasertsuk, J.T. Benson, F.B. Enders, and P. Angulo The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20 years Gut 58 2009 1538 1544
127. P. Socha, A. Horvath, P. Vajro, P. Dziechciarz, A. Dhawan, and H. Szajewska Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review J Pediatr Gastroenterol Nutr 48 2009 587 596
128. V. Nobili, G. Svegliati-Baroni, A. Alisi, L. Miele, L. Valenti, and P. Vajro A 360-degree overview of paediatric NAFLD: recent insights J Hepatol 58 2013 1218 1229
129. S.E. Baumeister, H. Völzke, P. Marschall, U. John, C.O. Schmidt, and S. Flessa Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation Gastroenterology 134 2008 85 94 (Pubitemid 350309322)
130. H.J. de Silva, and A.S. Dassanayake Non-alcoholic fatty liver disease: confronting the global epidemic requires better awareness J Gastroenterol Hepatol 24 2009 1705 1707
131. A.K. Daly, S. Ballestri, L. Carulli, P. Loria, and C.P. Day Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease Expert Rev Gastroenterol Hepatol 5 2011 253 263
132. M.V. Machado, and H. Cortez-Pinto Gut microbiota and nonalcoholic fatty liver disease Ann Hepatol 11 2012 440 449
133. T. Le Roy, M. Llopis, P. Lepage, A. Bruneau, S. Rabot, and C. Bevilacqua Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice Gut 2013 [in press]
134. M. Mouzaki, E. Comelli, B. Arendt, J. Bonengel, S. Fung, and S. Fischer Intestinal microbiota in patients with non-alcoholic fatty liver disease Hepatology 2013 10.1002/hep.26319
135. K.V. Kowdley, P. Belt, L.A. Wilson, M.M. Yeh, B.A. Neuschwander-Tetri, and N. Chalasani NASH Clinical Research Network. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease Hepatology 55 2012 77 85
136. L. Valenti, S. Moscatiello, E. Vanni, A.L. Fracanzani, E. Bugianesi, and S. Fargion Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling-a propensity score-adjusted observational study QJM 104 2011 141 149